Marie-Louise Fjällskog, MD, Ph.D

Board Member
Marie-Louise Fjällskog, MD, PhD (born 1964), Board Member since 2020.

Nationality: Swedish.
Education/Background: Physician (oncology specialist) educated at Uppsala University, where she became Associate Professor in Oncology in 2008. Over 25 years of experience in clinical oncology, translational research, and drug development. Currently Chief Medical Officer at Exscientia. Formerly Global Clinical Program Leader at Novartis, responsible for the development of targeted treatments against CDK4/6, BCL-2, and immunotherapies (CSF-1, PD-1, and CD73).

Holdings: 255 600 LTIP instruments.
Independent of the company, its management, and major shareholders.